{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpce.simplecast.com%2Fepisodes%2Fprostate-cancer-part-2-C9uedYlJ","width":444,"version":"1.0","type":"rich","title":"The New Array of Choices in Prostate Cancer—What’s Best for Your Patients? Part 2","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/b59f784a-ba6f-4e7f-9966-558aadf1218e/pce-prostate-cancer-part-2-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b6aec6ad-5fa0-4698-ad29-360991f0bcc8\" height=\"200\" width=\"100%\" title=\"The New Array of Choices in Prostate Cancer—What’s Best for Your Patients? Part 2\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast, Rana R. McKay, MD, and Arjun Balar, MD, discuss current treatment strategies and best approaches for patients with metastatic and nonmetastatic castration-resistant or castration-sensitive prostate cancers, including treatment selection and adverse event management. Nurse practitioner Terran W. Sims, MSN, ACNP-C, CNN-BC, COCN, moderates.\nClaim your credit at pce.is/GIGU.\n"}